Literature DB >> 34275285

Tumor-Specific ONOO- Nanogenerator for Improved Drug Delivery and Enhanced Chemotherapy of Tumor.

Ying Chen1, Zi-Hao Li1, Pei Pan1, Run-Yao Zeng1, Xian-Zheng Zhang1.   

Abstract

Multiple biological barriers in solid tumors severely restrict the penetration of nanomedicines, which is a main cause for therapeutic failure in traditional tumor treatment. Here, a tumor-specific nanogenerator of peroxynitrite (ONOO-), prepared by loading cisplatin and sodium nitroprusside into poly(d,l-lactide-co-glycolide) polymersomes, was designed to improve drug delivery and enhance tumor chemotherapy. After a cascade of nicotinamide adenine dinucleotide phosphate oxidases catalysis and glutathione reduction, the nanogenerator, namely, PMCS, could selectively induce the generation of ONOO- in tumor. The generated ONOO- could not only strengthen vascular permeability significantly but also improve the accumulation and penetration of PMCS in tumor by activating matrix metalloproteinases-mediated degradation of extracellular matrix. Along with endocytosis, PMCS released cisplatin to induce tumor cell apoptosis. Moreover, free cisplatin liberated from dead cells infected neighboring tumor cells quickly via ONOO--mediated up-regulated copper transporter 1, further amplifying chemotherapeutic efficacy. This study advances ONOO- as a potent modality to address the main issues of therapeutic delivery, including but not limited to chemotherapy.

Entities:  

Keywords:  chemotherapy; drug delivery; nanogenerator; peroxynitrite; tumor treatment

Year:  2021        PMID: 34275285     DOI: 10.1021/acsnano.1c01312

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  2 in total

Review 1.  Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy.

Authors:  Zhiyan Li; Xianghui Li; Shichao Ai; Song Liu; Wenxian Guan
Journal:  Int J Nanomedicine       Date:  2022-06-17

2.  Effects on the crystallization behavior and biocompatibility of poly(LLA-ran-PDO-ran-GA) with poly(d-lactide) as nucleating agents.

Authors:  Tiantang Fan; Jingwen Qin; Fen Dong; Xiao Meng; Yanqi Li; Ying Wang; Qing Liu; Guannan Wang
Journal:  RSC Adv       Date:  2022-04-06       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.